Skip Nav Destination
Issues
1 June 2015
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Research Articles
Folate Pathway Gene Polymorphisms and Risk of Childhood Brain Tumors: Results from an Australian Case–Control Study
Kathryn R. Greenop; Rodney J. Scott; John Attia; Carol Bower; Nicholas H. de Klerk; Murray D. Norris; Michelle Haber; Sarra E. Jamieson; Frank M. van Bockxmeer; Nicholas G. Gottardo; Lesley J. Ashton; Bruce K. Armstrong; Elizabeth Milne
Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort
Jennifer Ose; Helena Schock; Anne Tjønneland; Louise Hansen; Kim Overvad; Laure Dossus; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopolou; Vassiliki Benetou; Pagona Lagiou; Giovanna Masala; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H. B(as). Bueno-de-Mesquita; Petra H. M. Peeters; N. Charlotte Onland-Moret; Elisabete Weiderpass; Inger T. Gram; Soledad Sánchez; Mireia Obon-Santacana; Maria-José Sànchez-Pérez; Nerea Larrañaga; José María Huerta Castaño; Eva Ardanaz; Jenny Brändstedt; Eva Lundin; Annika Idahl; Ruth C. Travis; Kay-Tee Khaw; Sabina Rinaldi; Isabelle Romieu; Melissa A. Merritt; Marc J. Gunter; Elio Riboli; Rudolf Kaaks; Renée T. Fortner
Short Communication
Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma
David C. Gibbs; Irene Orlow; Peter A. Kanetsky; Li Luo; Anne Kricker; Bruce K. Armstrong; Hoda Anton-Culver; Stephen B. Gruber; Loraine D. Marrett; Richard P. Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J. Busam; Anne E. Cust; David W. Ollila; Colin B. Begg; Marianne Berwick; Nancy E. Thomas; on behalf of the GEM Study Group
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.